Elevated XRCC5 expression level can promote temozolomide resistance and predict poor prognosis in glioblastoma.
Oncol Lett. 2021 Jun;21(6):443. doi: 10.3892/ol.2021.12704. Epub 2021 Apr 6.
Oncol Lett. 2021.
PMID: 33868481
Free PMC article.